• US: +1-408-610-2300
  • Toll Free: +1-866-831-4085
  • Login / Register
Toxoid Vaccines Market Size & Share, 2021 | Industry Research Report

Toxoid Vaccines Market Research Report 2021

Report ID: MN17613530  |  Published: August 2016  |  No of Pages: 103
Format: Electronic (PDF)  |  Industry: Pharmaceuticals  |  Publisher: QY Research

Global toxoid vaccines market is segmented into product, end-users and geographic regions. Toxoid vaccine is a vaccine made from a toxin (poison) that has been made nontoxic but that elicits an immune response alongside the toxin. They are based on the toxin shaped by certain bacteria (e.g. tetanus or diphtheria).The toxin invades the bloodstream and is principally responsible for the symptoms of the disease. The protein-based toxin is rendered nontoxic (Toxoid Inactivated or killed toxin (poison) used in vaccine production.) and used as the antigen in the vaccine to elicit immunity. To augment the immune reaction, the toxoid is adsorbed to aluminum or calcium salts, which serve as adjuvant.

Micro-organisms cause damage to the body throughout dissimilar mechanisms and pathways. A number of bacteria exert their damaging belongings throughout the discharge of potent chemicals called. These toxins disrupt normal bodily functions, and are finally accountable for disease. As soon as a toxin has been recognized as the main means by which a bacterium causes disease, it can be used to immunize the body alongside that particular pathogen. Throughout treatment processes like chemical or heat inactivation, a toxin can be made into a risk-free toxoid. Toxoids keep the same structure as their parent compound, the damaging toxin, but can no longer injure the body, consequently flattering a useful vaccination tool.

These vaccines are used when a bacterial toxin is the main reason of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. The important point to make about toxoids is that even with losing their ability to injure the body; they retain significant possessions called ‘immunogenicity’. This fundamentally means that they are still documented by the body as harmful; thereby suggest an immune response that prepares the body for prospect infection and introduction to the original toxin.

When the immune system receives a vaccine containing an undamaging toxoid, it learns how to fight off the natural toxin. The resistant system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines. Toxoids are used as vaccines because they induce an immune response to the original toxin or increase the response to another antigen since the toxoid markers and toxin markers are preserved.

Toxoid Vaccines Market Report is segmented, by product type, pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, and MMR. Toxoid Vaccines Market Report is segmented, by end-users into Pediatric and Adult.

Toxoid Vaccines Market is geographically segmented as North America, China, Europe, Japan, India, and Southeast Asia. Toxoid Vaccines Market, mainly driven by growing prevalence of Animal Diseases and Increasing Incidences of Zoonotic Diseases in Humans and the prevalence of tetanus and Diphtheria diseases.

The Toxoid Vaccines Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. All of these products experienced a positive growth till 2018 with an increased awareness for procedures and sophisticated diagnostic techniques. Europe is the fastest growing market owing to extremely prepared livestock sector. This growth is credited to its highly prearranged livestock farms and the huge demand for livestock products, such as food (meat, egg, milk, and its byproducts) and non-food items from the European population. The demand for livestock products is high in European countries

North America accounts for the second leading share. Rise in companion & Farm animal and an augment in reserves by companies helped to boost the market in the region. Continuous R&D investments by leading players for the development of new, innovative, and more-effective vaccines have also helped to boost the animal vaccines market in the region. Asian countries are potential markets for the animal vaccines market with an enormousnumeral of domesticated animals, such as dogs, chicken, cattle, and pigs.

The animal vaccines market in the Asian region has changed extraordinarily over the past few years and will continue to grow what with the growing numbers of people adopting pets, especially in India and China.

The Key Players in the Toxoid Vaccines market include Astellas Pharma Inc, CSL Limited, Emergent BioSolutions, Inc, GlaxoSmithKline, Johnson & Johnson, Med Immune, LLC, Merck & Co, Pfizer, Sanofi Pasteur, Serum Institute India Pvt. Ltd. (India).

This report studies Toxoid Vaccines in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
• Astellas Pharma Inc
• CSL Limited
• Emergent BioSolutions, Inc
• GlaxoSmithKline
• Johnson & Johnson
• MedImmune, LLC
• Merck & Co
• Pfizer
• Sanofi Pasteur
• Serum Institute
• India Pvt. Ltd. (India)

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Toxoid Vaccines in these regions, from 2011 to 2021 (forecast), like
• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into• Pneumococcal
• Influenza
• HPV
• Hepatitis
• Rotavirus
• DTP
• Polio
• MMR

Split by application, this report focuses on sales, market share and growth rate of Toxoid Vaccines in each application, can be divided into
• Pediatric
• Adult
• Application 3

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service
  • 100% Secure Payments
  • Our Promise
  • 100% Service Assurance
  • Market Monitoring
  • Service Flexibility
  • 24X5 Care available